All other patient and clinical characteristics including age, menopausal status, race, tumor subtype (ER/PR/HER2), nodal status, lymphatic and vascular involvement, number and sites of metastases, definitive surgery, and adjuvant therapy were similar among the three histologic groups (Table 1). This evidence concerns the gene PGR and neoplasm.